Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
As monsoon takes hold, anti-infective, respiratory drugs' demand surgesMonsoon led to a surge in demand for respiratory, anti-infective, and anti-malarial products. The respiratory market saw a notable increase...
Indian pharma market grows over 9 per cent in DecemberAmong the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last mont...